Figure 8
From: BCL2A1 regulates Canady Helios Cold Plasma-induced cell death in triple-negative breast cancer
Silencing of BCL2A1 expression increases cell death at G1 phase of the cell cycle after CHCP treatment. (A) Representative pictures of IncuCyte live cell image showing the live state of MDA-MB-231-Cell Cycle Green/Red reagent stable cells treated with/without CHCP treatment or siRNA BCL2A1. The CHCP treated cells recover 50% of the time but when transfected with siRNA-BCL2A1 in combination with CHCP, such recovery is inhibited. (B) Shows the line graph for the quantification of the cells in G1, G1-S, S/G2/M, and M-G1 phases after CHCP treatment corresponding to section A.
